Go to Body

Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis.

페이지 정보

작성자 profile_imageadmin 작성일 19-04-15 16:50
93회 0건



Background Pancreatic neuroendocrine tumors (PNET) include heterogeneous tumors with a variable degree of inherent biologic aggressiveness represented by the histopathologic grade. Although several studies investigated the computed tomography (CT) characteristics which can predict the histopathologic grade of PNET, accurate prediction of the PNET grade by CT examination alone is still limited. Purpose To investigate the important CT findings and CT texture variables for prediction of grade of PNET. Material and Methods Sixty-six patients with pathologically confirmed PNETs (grade 1 = 45, grades 2/3 = 21) underwent preoperative contrast-enhanced CT. Two reviewers determined the presence of predefined CT findings. CT texture was also analyzed on arterial and portal phase using both two-dimensional (2D) and three-dimensional (3D) analysis. Multivariate logistic regression analysis was performed in order to identify significant predictors for tumor grade. Results Among CT findings and CT texture variables, the significant predictors for grade 2/3 tumors were an ill-defined margin (odds ratio [OR] = 7.273), lower sphericity (OR = 0.409) on arterial 2D analysis, higher skewness (OR = 1.972) and lower sphericity (OR = 0.408) on arterial 3D analysis, lower kurtosis (OR = 0.436) and lower sphericity (OR = 0.420) on portal 2D analysis, and a larger surface area (OR = 2.007) and lower sphericity (OR = 0.503) on portal 3D analysis ( P < 0.05). Diagnostic performance of texture analysis was superior to CT findings (AUC = 0.774 vs. 0.683). Conclusion CT is useful for predicting grade 2/3 PNET using not only the imaging findings including an ill-defined margin, but also the CT texture variables such as lower sphericity, higher skewness, and lower kurtosis.

KEYWORDS: Abdomen/gastrointestinal; adults; computed tomography (CT); pancreas; primary neoplasms

  • 상호명 ㅣ MEDICALIP
    대표이사 ㅣ 박상준    대표번호 ㅣ 02-2135-9148    사업자등록번호 ㅣ 406-81-04085
    사업장소재지 ㅣ 7F, Changgyeong Building, 174, Yulgok-ro, Jongno-gu, Seoul, Republic of Korea
Copyright2018. MEDICAL IP. All Rights Reserved.